AntibioticMech

lancovutide

CHEBI:77834 ·resolve ·ANTIMICROBIAL_UNSPECIFIED ·EXACT SEEDED

A 19-membered heterodetic cyclic peptide that is isolated from Streptoverticillium cinnamoneus. It exhibits antiproliferative properties and induces apoptosis in tumour cells and has been used for treatment of cystic fibrosis. — ChEBI

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC89H125N23O25S3
Charge0
Average mass2013.316 Da
Monoisotopic mass2011.83791 Da
SourceChEBI
InChIKeySFWLDKQAUHFCBS-WWXQEMPQSA-N

SMILES

[H][C@@]12NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CCCN3C(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@@H]3CNCCCC[C@@H](C(=O)O)NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@]([H])([C@@H](O)C(=O)O)NC(=O)[C@H](CSC[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSC4C)C(=O)N[C@@H](CS[C@H]1C)C(=O)N3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccccc1)NC2=O

InChI

InChI=1S/C89H125N23O25S3/c1-44(2)67-85(131)107-60-42-138-41-59-80(126)106-61-43-140-46(4)69(87(133)103-56(76(122)108-67)35-49-23-12-7-13-24-49)109-77(123)55(34-48-21-10-6-11-22-48)102-83(129)62-27-18-32-112(62)66(116)39-96-73(119)54(33-47-19-8-5-9-20-47)101-79(125)58(104-81(61)127)37-94-31-17-15-26-53(88(134)135)100-86(132)68(110-78(124)57(36-64(93)114)97-65(115)38-95-84(130)70(111-82(60)128)71(117)89(136)137)45(3)139-40-50(91)72(118)98-51(25-14-16-30-90)74(120)99-52(75(121)105-59)28-29-63(92)113/h5-13,19-24,44-46,50-62,67-71,94,117H,14-18,25-43,90-91H2,1-4H3,(H2,92,113)(H2,93,114)(H,95,130)(H,96,119)(H,97,115)(H,98,118)(H,99,120)(H,100,132)(H,101,125)(H,102,129)(H,103,133)(H,104,127)(H,105,121)(H,106,126)(H,107,131)(H,108,122)(H,109,123)(H,110,124)(H,111,128)(H,134,135)(H,136,137)/t45?,46-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59+,60-,61-,62-,67-,68+,69+,70-,71+/m0/s1

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Drug registries

Identifiers that name a drug rather than a structure. One of these can cover a parent compound, its salts and its stereoisomers, which this corpus keeps as separate records, so it is not an equivalence of structure.

Patents and articles

Documents about this compound. A patent covers a class and an article covers a topic; neither identifies a structure.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
CHEBI CHEBI:77834 lancovutide antibioticmech:chebi-55cec429d7 2026-08-30

Resistance mechanisms

2 source-backed resistance determinants or associations, with ARO grounding where reported. Grouped by reported mechanism type.

UNKNOWN 2
UNKNOWN
DeterminantARO IDOrganismGene familiesEvidence
Cinorf10-associated reduced susceptibility to duramycin
Both compared subjects are laboratory derivatives of the 1326 background, including a vector control. Protection varies with expression context; gene presence alone did not predict protection across the tested contexts. NCBITaxon:1200984 denotes the background, not either derivative. UniProtKB:Q83VX7 is reference-only: its source strain DSM 40005 differs from the study's DSM 40646 donor. Source-reported duramycin maps to the existing ChEBI exact synonym of lancovutide; this is not direct cinnamycin AST. No clinical category, numerical AST or exact allele is assigned.
— Streptomyces lividans NCBITaxon:1916 cinorf10
  • PMID:27858169 (Relevant primary Results and native Figures 3-5 were inspected. The claims retain qualitative comparisons and do not complete whole-record review.)
Qualitative source-reported disk-growth comparison with accompanying lipid analysis
cinorf10/CinKR contribution to native-host duramycin protection
Separate laboratory derivatives of the reported DSM 40646 background provide loss-of-protection evidence, not resistant alterations or individual gene sufficiency. Production-indicator assays are distinct. These comparisons do not establish direct CinK ligand binding. UniProtKB:Q83VX7, UniProtKB:Q83VX8 and UniProtKB:Q83VX9 remain reference candidates with different strain context; no derivative TaxID or genome is assigned. Source-reported duramycin maps to the existing ChEBI exact synonym of lancovutide; this is not direct cinnamycin AST. No clinical category, numerical AST or exact allele is assigned.
— Streptomyces cinnamoneus NCBITaxon:53446 cinorf10, cinK, cinR
  • PMID:27858169 (Relevant primary Results and native Figures 3-5 were inspected. The claims retain qualitative comparisons and do not complete whole-record review.)
Qualitative source-reported disk-growth comparisons

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-09-10 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. CURATED_RESISTANCE_EVIDENCE 2026-10-09 · codex · LLM-assisted

    Added two qualitative primary-backed duramycin susceptibility associations, retaining host, comparator and regulatory context. UniProt references and background taxonomy remain distinct from experimental alleles and derivatives. Existing source fields preserved; whole-record review remains open.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (lancovutide) · CultureMech · NaturalProductMech · PathwayMech · TraitMech